Form 4 for TXG 10x Genomics, Inc.
Accepted 2023-05-15 00:00:00 ET · period of report 2023-05-11 · accession 0001610717-23-000035 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-15 | 2023-05-11 | TXG | Mammen Mathai | Dir | M - OptEx | $1.16 | +200.0K | 202.7K | +7,286% | +$232.0K |
| D | 2023-05-15 | 2023-05-11 | TXG | Mammen Mathai | Dir | S - Sale+OE | $52.82 | -33.0K | 169.7K | -16% | -$1.74M |
| D | 2023-05-15 | 2023-05-11 | TXG | Mammen Mathai | Dir | M - OptEx | $0.00 | -200.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-05-11 | M | A | 200,000 | $1.16 | 202,745 | D | — | — | |
| 2 | Common | Class A Common Stock | 2023-05-11 | S | D | 33,000 | $52.82 | 169,745 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $52.43 to $53.26. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 3 | Derivative | Stock Option (right to buy) | 2023-05-11 | M | D | 200,000 | $0.00 | 0 | D | $1.16 · — to 2027-06-12 | 200,000 Class A Common Stock | (F2) All of the shares subject to the option are fully vested and exercisable as of the date hereof. |